JP Morgan Chase
KURA icon

JP Morgan Chase’s Kura Oncology KURA Stock Holding History

JP Morgan Chase’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,600
Closed -$216K – 6209
2020
Q4 		$216K Buy
+6,600
New +$232K ﹤0.01% 4782

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's KURA Position: Q1 2026 in Review

JP Morgan Chase increased its Kura Oncology (KURA) stake by 31% in Q1 2026, buying an estimated $107K and bringing the position to 52,572 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #5144.

JP Morgan Chase first reported a position in KURA in Q3 2017 and has held it in 35 quarters since. The position peaked at $10.3M in Q2 2022. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • JP Morgan Chase held 52,572 shares of Kura Oncology worth $406K as of Q1 2026.
  • JP Morgan Chase bought 12,471 Kura Oncology shares in Q1 2026, an estimated $107K.
  • Kura Oncology made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5144 holding.
  • JP Morgan Chase first reported a position in Kura Oncology in Q3 2017 and has held it in 35 quarters since.
  • JP Morgan Chase's Kura Oncology position peaked at $10.3M in Q2 2022.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.